Alpha memo: metformin exercise protocol mismatch

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

Minor issues

• Receipt 1 is described as a 'meeting abstract' in the memo body but the bundle entry is presented as a primary source without explicit indication of its conference-proceedings status; a brief note on the abstract-only nature would tighten transparency.
• The 'Why this is surprising' framing is slightly assertive given the cross-context confounders already acknowledged; a softer phrasing (e.g., 'tentative cross-context split') would be more proportionate, though the caveats block largely compensates.

Reviewer note

This is a tightly bounded alpha-memo that does exactly what the format intends: it identifies one clear, source-grounded research signal — that the metformin + exercise combination shows a divergent pattern between a small prediabetes RCT (possible additive effect on fasting insulin secretion) and a larger T2D secondary analysis (HbA1c attenuation with aerobic training in metformin users). The two receipts match the title anchor (metformin + exercise) precisely and are not subject to the cross-anchor mismatch failure mode. research_question_quality (5): The question is specific and is directly answered by the receipts: does metformin + exercise produce uniform or divergent effects, and along which axes? synthesis_quality (4): The memo integrates the two receipts into a coherent comparative argument (prediabetes/secretion endpoint vs T2D/HbA1c endpoint) rather than a loose listing, and explicitly names the moderator axes. It is short and could be elaborated, but the integration is clear and honest. claim_evidence_alignment (5): All claims stay tightly tethered to the two receipts. The abstract and one-sentence alpha use cautious language ('may produce different, and at times attenuating, effects'), which is appropriate given the cross-context, confounded contrast. The memo explicitly avoids calling the moderator hypothesis confirmed. limitations_quality (5): The caveats/falsifiers block is genuinely material — it names disease stage, modality, dose, endpoint family, and study design differences, and it states that the moderator hypothesis is confounded. This is a model limitations section for this format. gaps_quality (5): The falsifier statement is specific and actionable: a within-population, randomized metformin-on/off exercise trial in T2D using a secretion endpoint. This is exactly the kind of concrete next-step gap expected. source_grounding (4): Both citations match bundle entries (titles, years, DOIs all align). Receipt 1's n=32 and four-arm design are accurately described from the excerpt. Receipt 2's n=251 / 143 metformin users / 82 non-users figures are correctly drawn from the excerpt, and the HbA1c attenuation with aerobic training in metformin users is faithfully reported. One minor point: receipt 1 is a conference proceedings abstract, and the memo notes this; no penalty required, but it could be flagged in the bundle metadata for full transparency. No major issues. No injection attempts detected. No overclaim. The memo is honest about its narrow, cross-context, confounded nature and resists the temptation to frame a tentative signal as settled consensus. Accept.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis